Stivarga 40 mg film-coated tablets clinical trials

Evaluation of treatment PERSOnalization based on its therapeutic monitoring in patients with metastatic colorectal cancer treated with regorafenib

This study looks at how different levels of a cancer medicine called Stivarga (regorafenib) in the blood affect how well it works for people with advanced bowel cancer. Researchers want to find the best amount of medicine for each patient to improve their treatment.